Somatic growth outcomes in response to an individualized neonatal sodium supplementation protocol

Elliot J Stalter1, Silvia L Verhofste1, John M Dagle1

  • 1Stead Family Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa, IA, USA.

Insights

Protocolized sodium (Na) supplementation improved growth and reduced mechanical ventilation time in extremely preterm infants. This approach did not increase the incidence of common morbidities in this vulnerable population.

Area of Science:

  • Neonatal Medicine
  • Pediatric Nutrition
  • Critical Care Pediatrics

Background:

  • Optimizing sodium (Na) balance is crucial for preterm infants.
  • Current supplementation protocols lack standardization, particularly regarding urine Na monitoring.
  • Effective Na management impacts growth and clinical outcomes in extremely preterm neonates.

Purpose of the Study:

  • To evaluate the impact of a novel Na supplementation protocol guided by urine Na concentration.
  • To assess effects on growth parameters and incidence of morbidities in preterm infants.

Main Methods:

  • Retrospective cohort study comparing infants before (2012-15) and after (2016-20) protocol implementation.
  • Included infants 260/7-336/7 weeks gestational age (GA).
  • Analyzed growth (weight, head circumference) and morbidities using generalized linear models.

Main Results:

  • For infants 260/7-296/7 weeks GA, the protocol improved body weight and head circumference z-scores.
  • Associated with decreased duration of mechanical ventilation in the same subgroup.
  • No significant impact on growth for infants 30-336/7 weeks GA; no increase in hypertension, hypernatremia, BPD, NEC, or sepsis.

Conclusions:

  • Protocolized Na supplementation positively influences growth and reduces mechanical ventilation needs in extremely preterm infants.
  • This evidence-based approach appears safe, not elevating risks for major neonatal morbidities.
Abstract